Angiotensin Ii Injection
Product Images NDC 68083-553

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Angiotensin Ii (NDC 68083-553). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Angiotensin-fig-1 (Angiotensin Fig 1)

A forest plot showing odds ratios with 95% confidence intervals for various patient characteristics comparing treatment effects of Angiotensin II versus placebo. Characteristics include age, gender, race, baseline BMI, geographical location, baseline MAP, APACHE II, dialysis status, creatinine clearance, ARDs X-ray findings, history of ACEi and ARB use, baseline albumin, and baseline norepinephrine equivalent dose, with data points and confidence intervals plotted on a logarithmic odds ratio scale.*

FDA Label Image

Angiotensin-ii-carton-label (Angiotensin Ii Carton Label)

Packaging label for Angiotensin II Injection 2.5 mg/mL, a human prescription drug in single-dose 1 mL vials for intravenous use. The label includes dosage instructions emphasizing dilution prior to infusion, storage conditions between 2°C and 8°C, and manufacturer details as Gland Pharma Limited, Hyderabad, India. The product is Rx only.*

FDA Label Image

Angiotensin-ii-chemcial-structure (Angiotensin Ii Chemcial Structure)

Chemical structure diagram of angiotensin II, depicting the molecular arrangement of atoms and bonds characteristic of this peptide active ingredient.*

FDA Label Image

Angiotensin-ii-container-label (Angiotensin Ii Container Label)

Label for Angiotensin II Injection 2.5 mg/mL, a 1 mL single-dose vial for intravenous use. Contains angiotensin II acetate equivalent to 2.5 mg, with inactive ingredients mannitol, water for injection, sodium hydroxide, and hydrochloric acid for pH adjustment. Manufactured by Gland Pharma Limited, Hyderabad, India. Includes storage instructions at 26-86C and notes to dilute prior to IV infusion and discard unused portion. Features NDC 68083-553-01 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.